Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities

• 2023

  Log in to bookmark this resource.

  Log in
• Didier Pinquier; Pascal Crépey; Pierre Tissières; Astrid Vabret; Jean-Christophe Roze; François Dubos
PMID: 36520324DOI: https://dx.doi.org/10.1007/s40121-022-00737-2

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This article describes the importance of preventing respiratory syncytial virus (RSV) in young children in France. It highlights the need for a strong partnership between parents, healthcare professionals, and public health authorities to protect children from RSV. The virus causes many hospitalizations each year, especially in infants under one year old. Strategies like maternal vaccination and long-acting antibodies are being explored to prevent infections. Non-pharmaceutical measures such as handwashing and social distancing can also help reduce transmission. Effective prevention programs could ease the burden on healthcare systems during RSV season by reducing hospital admissions for severe cases.

---

Tags

Focus Area: Infectious Disease

Audiences: Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Child; France; Health Personnel; Infant; Parents; Public Health Administration; Respiratory Syncytial Virus Infections; Immunization Programs

Institutions: University of Rouen Normandy; University of Rennes; Université Paris-Saclay

---

More like this

Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson Has Not Been Learnt 2023 · Hôpital Antoine-Béclère AP-HP, Université Paris-Saclay, American College of Emergency Physicians, Hospital General Universitario Gregorio Marañón, St. Marien Children's Hospital, University Medical Centre Utrecht, Respiratory Syncytial Virus NETwork (ReSViNET) Foundation, University Hospital of Padova Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US 2023 · University of Oxford, Imperial College London, Columbia University, University of Copenhagen, National University of Singapore, Queen Mary University of London RSV Neutralizing Antibodies Following Nirsevimab and Palivizumab Dosing 2024 · AstraZeneca, State University of New York - Upstate Medical University, Seattle Children's Hospital, Northwestern University

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---